Panacea Index Logo

Command Palette

Search for a command to run...

Feasibility study to assess the delivery of a lifestyle intervention (TreatWELL) for patients with colorectal cancer undergoing potentially curative treatment.

BMJ open
January 1, 1970
Maureen Macleod et al. (10 authors)
Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to assess the feasibility of delivering and evaluating a lifestyle programme, including walking, for patients with colorectal cancer undergoing curative treatments.

Results Summary

The study found that walking and other physical activity measures were part of the intervention, but the walk test was not achieved by all participants, and evaluation measures were inconsistently collected across phases.

Population

Adults with stage I-III colorectal cancer in NHS Tayside.

Effective Dosage

Not specified

Duration

Three phases (presurgery, surgical recovery, post-treatment recovery) with a median intervention delivery time of 5.5 hours.

Interactions

None mentioned

Extracted Claims (7)
InterventionDirectionEndpointPopulationDosageImpactClaim #
lifestyle programme targeting smoking, alcohol, physical activity, diet and weight management
increase
intervention acceptability
patients with stage I-III colorectal cancer
-
was rated highly
#1
lifestyle programme targeting smoking, alcohol, physical activity, diet and weight management
decrease
NHS staff support
-
-
had limited support
#2
lifestyle programme targeting smoking, alcohol, physical activity, diet and weight management
decrease
programme implementation
-
-
had difficulties
#3
lifestyle programme targeting smoking, alcohol, physical activity, diet and weight management
no change
evaluation measures (except walk test)
patients with stage I-III colorectal cancer
-
were achieved by all participants
#4
lifestyle programme targeting smoking, alcohol, physical activity, diet and weight management
no change
evaluation measures (except walk test)
patients with stage I-III colorectal cancer
<90%
were achieved by most
#5
lifestyle programme targeting smoking, alcohol, physical activity, diet and weight management
decrease
evaluation measures (except walk test)
patients with stage I-III colorectal cancer
<20%
were achieved by
#6
lifestyle programme targeting smoking, alcohol, physical activity, diet and weight management
increase
body mass index
the majority of participants
>25 kg/m²
had
#7
Abstract

OBJECTIVES: To assess the feasibility of delivering and evaluating a lifestyle programme for patients with colorectal cancer undergoing potentially curative treatments. STUDY DESIGN: Non-randomised feasibility trial. SETTING: National Health Service (NHS) Tayside. PARTICIPANTS: Adults with stage I-III colorectal cancer. INTERVENTION: The programme targeted smoking, alcohol, physical activity, diet and weight management. It was delivered in three face-to-face counselling sessions (plus nine phone calls) by lifestyle coaches over three phases (1: presurgery, 2: surgical recovery and 3: post-treatment recovery). PRIMARY OUTCOME: Feasibility measures (recruitment, retention, programme implementation, achieved measures, fidelity, factors affecting protocol adherence and acceptability). SECONDARY OUTCOMES: Measured changes in body weight, waist circumference, walking and self-reported physical activity, diet, smoking, alcohol intake, fatigue, bowel function and quality of life. RESULTS: Of 84 patients diagnosed, 22 (26%) were recruited and 15 (18%) completed the study. Median time for intervention delivery was 5.5 hours. Coaches reported covering most (>70%) of the intervention components but had difficulties during phase 2. Evaluation measures (except walk test) were achieved by all participants at baseline, and most (<90%) at end of phase 2 and phase 3, but <20% at end of phase 1. Protocol challenges included limited time between diagnosis and surgery and the presence of comorbidities. The intervention was rated highly by participants but limited support from NHS staff was noted. The majority of participants (77%) had a body mass index>25 kg/m CONCLUSIONS: To make this intervention feasible for testing as a full trial, further research is required on (a) recruitment optimisation, (b) appropriate assessment tools, (c) protocols for phase 2 and 3, which can build in flexibility and (d) ways for NHS staff to facilitate the programme. TRIAL REGISTRATION NUMBER: ISRCTN52345929; Post-results.

Medical Subject Headings (MeSH)
AgedAged, 80 and overBody Mass IndexBody WeightColorectal NeoplasmsDietExerciseFeasibility StudiesFemaleHealth PromotionHumansLife StyleMaleMiddle AgedQuality of LifeTreatment OutcomeUnited Kingdom
Study Links
Quality Scores
SafetyNot Assessed
Efficacy50/10
Quality65/10
Citation Metrics
Total Citations11
Citations/Year1.6
Relative Citation Ratio0.59
NIH Percentile32.1%
Research Impact Scores
APT Score0.50
Weight Score1.47
Normalized Score0.53
Related Supplements